Autres langues Jianmin Pharmaceutical Group Co.,Ltd.

Actions

600976

CNE000001HB7

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
50,5 ^CNY	-0,32%		-7,10%	-22,61%

19/04	Jianmin Pharmaceutical Group Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
15/03	Jianmin Pharmaceutical Group Co. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Jianmin Pharma Gets Nod to Market Asthma Drug	16/04
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Jianmin Pharmaceutical’s Drugs Remain Covered by China’s National Medical Insurance	15/12
Jianmin Pharmaceutical Earmarks 132 Million Yuan to Expand China Factory; Shares Jump 8%	17/11
Jianmin Pharma Gets Nod to Market Drug For Children's Acute Bronchitis	23/10/23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	21/10/23
Jianmin Pharma Receives Nod to Market Oral Solution For Epilepsy Patients	17/10/23
Jianmin Pharmaceutical Group Co.,Ltd.(XSSC:600976) added to S&P Global BMI Index	18/09/23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	08/08/23
Jianmin Pharmaceutical Group Co.,Ltd. completed the acquisition of 6.13% stake in HeraMED Limited from Hua Li Pharmaceutical Group Co.,Ltd.	25/07/23
Jianmin Pharma Gets Nod to Market Atomoxetine Hydrochloride Oral Solution; Shares Drop 3%	25/05/23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/04/23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
Jianmin Pharma's Liver, Stomach Disease Drug Included in China’s Medical Insurance Catalog	19/01/23
Jianmin Pharma to Buy 4.5% of Australia’s Hera Med for 8.4 Million Yuan	28/12/22
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21/10/22
Jianmin Pharmaceutical Group Co.,Ltd. intends to acquire Zhejiang Huafang Medical Care Co., Ltd from Holley Group Company Limited, Zhejiang Holley Investment Management Co., Ltd. and Suzhou Yuanyi Zhiyuan Equity Investment Partnership (Limited Partnership) for CNY 15.2 million.	17/08/22
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	19/07/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Jianmin Pharmaceutical Group Co.,Ltd.

Actions

600976

CNE000001HB7

Autres langues

Filtres